Gisbert J, Chaparro M
J Clin Med. 2024; 13(16).
PMID: 39200937
PMC: 11355176.
DOI: 10.3390/jcm13164795.
Chadalavada P, Afraz S, AlGhadir-AlKhalaileh M, Suarez Z, Swartz A, Rashid M
Crohns Colitis 360. 2024; 6(2):otae025.
PMID: 38711857
PMC: 11071514.
DOI: 10.1093/crocol/otae025.
Aslam N, Lo S, Sikafi R, Barnes T, Segal J, Smith P
Therap Adv Gastroenterol. 2022; 15:17562848221138160.
PMID: 36478780
PMC: 9720837.
DOI: 10.1177/17562848221138160.
Masuda M, Fukata N, Sano Y, Nishimon S, Aoi M, Tomiyama T
JGH Open. 2022; 6(9):612-620.
PMID: 36091323
PMC: 9446402.
DOI: 10.1002/jgh3.12796.
Park J, Cheon J
Korean J Intern Med. 2022; 37(5):895-905.
PMID: 35882566
PMC: 9449200.
DOI: 10.3904/kjim.2022.132.
Real-World Efficacy and Safety Monitoring for Predicting Continuation of Tofacitinib Therapy in Patients with Ulcerative Colitis.
Ishida N, Miyazu T, Tamura S, Tani S, Yamade M, Iwaizumi M
Dig Dis Sci. 2021; 67(8):3984-3992.
PMID: 34460029
PMC: 8403693.
DOI: 10.1007/s10620-021-07233-6.
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.
Lamb C, Kennedy N, Raine T, Hendy P, Smith P, Limdi J
Gut. 2019; 68(Suppl 3):s1-s106.
PMID: 31562236
PMC: 6872448.
DOI: 10.1136/gutjnl-2019-318484.
Optimizing the Use of Current Treatments and Emerging Therapeutic Approaches to Achieve Therapeutic Success in Patients with Inflammatory Bowel Disease.
Nakase H
Gut Liver. 2019; 14(1):7-19.
PMID: 30919602
PMC: 6974326.
DOI: 10.5009/gnl18203.
Evidence-based clinical practice guidelines for inflammatory bowel disease.
Matsuoka K, Kobayashi T, Ueno F, Matsui T, Hirai F, Inoue N
J Gastroenterol. 2018; 53(3):305-353.
PMID: 29429045
PMC: 5847182.
DOI: 10.1007/s00535-018-1439-1.
Time to clinical response and remission for therapeutics in inflammatory bowel diseases: What should the clinician expect, what should patients be told?.
Vasudevan A, Gibson P, van Langenberg D
World J Gastroenterol. 2017; 23(35):6385-6402.
PMID: 29085188
PMC: 5643264.
DOI: 10.3748/wjg.v23.i35.6385.
Do we know how to use corticosteroids in acute severe ulcerative colitis?.
Islam M, Grainger S
Frontline Gastroenterol. 2017; 3(4):248-251.
PMID: 28839676
PMC: 5369831.
DOI: 10.1136/flgastro-2012-100211.
Second Korean guidelines for the management of ulcerative colitis.
Choi C, Moon W, Kim Y, Kim E, Lee B, Jung Y
Intest Res. 2017; 15(1):7-37.
PMID: 28239313
PMC: 5323310.
DOI: 10.5217/ir.2017.15.1.7.
Common Pitfalls in Management of Inflammatory Bowel Disease.
Pasumarthy L, Srour J, Choudhary C
Gastroenterology Res. 2016; 2(4):200-208.
PMID: 27942275
PMC: 5139742.
DOI: 10.4021/gr2009.07.1305.
Amelioration of experimental colitis after short-term therapy with glucocorticoid and its relationship to the induction of different regulatory markers.
Sales-Campos H, de Souza P, Basso P, Nardini V, Silva A, Banquieri F
Immunology. 2016; 150(1):115-126.
PMID: 27618667
PMC: 5341502.
DOI: 10.1111/imm.12672.
Acute severe ulcerative colitis: from pathophysiology to clinical management.
Hindryckx P, Jairath V, DHaens G
Nat Rev Gastroenterol Hepatol. 2016; 13(11):654-664.
PMID: 27580687
DOI: 10.1038/nrgastro.2016.116.
A Comparison of Short- and Long-Term Therapeutic Outcomes of Infliximab- versus Tacrolimus-Based Strategies for Steroid-Refractory Ulcerative Colitis.
Endo K, Onodera M, Shiga H, Kuroha M, Kimura T, Hiramoto K
Gastroenterol Res Pract. 2016; 2016:3162595.
PMID: 26904108
PMC: 4745932.
DOI: 10.1155/2016/3162595.
The predictive variable regarding relapse in patients with ulcerative colitis after achieving endoscopic mucosal healing.
Yoshino T, Yamakawa K, Nishimura S, Watanabe K, Yazumi S
Intest Res. 2016; 14(1):37-42.
PMID: 26884733
PMC: 4754520.
DOI: 10.5217/ir.2016.14.1.37.
Medical Therapy of Active Ulcerative Colitis.
Burger M, Schmidt C, Teich N, Stallmach A
Viszeralmedizin. 2015; 31(4):236-45.
PMID: 26557831
PMC: 4608602.
DOI: 10.1159/000436959.
A Saudi Gastroenterology association position statement on the use of tumor necrosis factor-alfa antagonists for the treatment of inflammatory bowel disease.
Mosli M, Al-Harbi O, Feagan B, Almadi M
Saudi J Gastroenterol. 2015; 21(4):185-97.
PMID: 26228361
PMC: 4542416.
DOI: 10.4103/1319-3767.161635.
Classical and recent advances in the treatment of inflammatory bowel diseases.
Sales-Campos H, Basso P, Alves V, Fonseca M, Bonfa G, Nardini V
Braz J Med Biol Res. 2014; 48(2):96-107.
PMID: 25466162
PMC: 4321214.
DOI: 10.1590/1414-431X20143774.
